Hirotake Shiraiwa

An anti–glypican 3/CD3 bispecific T cell–redirecting antibody for treatment of solid tumors

Takahiro Ishiguro, Yuji Sano, Shunichiro Komatsu et al. · Science Translational Medicine · 2017 · 195 citations

A feasible method for expansion of peripheral blood lymphocytes by culture with immobilized anti-CD3 monoclonal antibody and interleukin-2 for use in adoptive immunotherapy of cancer patients

Teruaki Sekine, Hirotake Shiraiwa, Takamasa Yamazaki et al. · Biomedicine & Pharmacotherapy · 1993 · 65 citations

Cell Therapy, Immunology, Hematology +10

Engineering a bispecific antibody with a common light chain: Identification and optimization of an anti-CD3 epsilon and anti-GPC3 bispecific antibody, ERY974

Hirotake Shiraiwa, Atsushi Narita, Mika Kamata‐Sakurai et al. · Methods · 2018 · 51 citations

Engineering, Bispecific Antibody, Medicine +10

A bispecific antibody NXT007 exerts a hemostatic activity in hemophilia A monkeys enough to keep a nonhemophilic state

Yuri Teranishi-Ikawa, Tetsuhiro Soeda, Hikaru Koga et al. · Journal of Thrombosis and Haemostasis · 2023 · 34 citations · Full text

A defucosylated anti‐CD317 antibody exhibited enhanced antibody‐dependent cellular cytotoxicity against primary myeloma cells in the presence of effectors from patients

Takahiro Ishiguro, Shigeto Kawai, Kiyoshi Habu et al. · Cancer Science · 2010 · 22 citations · Full text